Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zweidler

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Oncogene|March 9, 2010
Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitorsM B Nilsson, P E Zage, L Zeng, et al.
Stem Cells and Development|February 13, 2015
Expression of a surface antigen (MA6) by peripheral blood CD34+ cells is correlated with improved platelet engraftment and may explain delayed platelet engraftment following cord blood transplantationPaul J Simmons, Simon N Robinson, Mark F Munsell, et al.
Blood|August 25, 2005
Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignanciesPatrick A Zweidler-McKay, Yiping He, Lanwei Xu, et al.
Investigational New Drugs|October 5, 2010
The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastomaAlejandro G Levy, Peter E Zage, Lauren J Akers, et al.
Molecular Cancer Therapeutics|June 11, 2009
Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathwayKenneth Thress, Terry Macintyre, Haiyun Wang, et al.
Cancer Genetics|February 14, 2015
Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray studyLinda B Baughn, Jaclyn A Biegel, Sarah T South, et al.
Antioxidants (Basel, Switzerland)|April 23, 2022
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy EfficacySankaranarayan Kannan, Mary E Irwin, Shelley M Herbrich, et al.
Molecular Cancer Therapeutics|June 23, 2019
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic LeukemiaSankaranarayanan Kannan, Marisa J L Aitken, Shelley M Herbrich, et al.
American Journal of Clinical Pathology|March 25, 2017
CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution ExperienceSergej Konoplev, Xinyan Lu, Marina Konopleva, et al.
Gastroenterology|January 14, 2012
Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cellsMaria I Almeida, Milena S Nicoloso, Lizhi Zeng, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Oncogene|March 9, 2010
Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitorsM B Nilsson, P E Zage, L Zeng, et al.
Stem Cells and Development|February 13, 2015
Expression of a surface antigen (MA6) by peripheral blood CD34+ cells is correlated with improved platelet engraftment and may explain delayed platelet engraftment following cord blood transplantationPaul J Simmons, Simon N Robinson, Mark F Munsell, et al.
Blood|August 25, 2005
Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignanciesPatrick A Zweidler-McKay, Yiping He, Lanwei Xu, et al.
Investigational New Drugs|October 5, 2010
The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastomaAlejandro G Levy, Peter E Zage, Lauren J Akers, et al.
Molecular Cancer Therapeutics|June 11, 2009
Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathwayKenneth Thress, Terry Macintyre, Haiyun Wang, et al.
Cancer Genetics|February 14, 2015
Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray studyLinda B Baughn, Jaclyn A Biegel, Sarah T South, et al.
Antioxidants (Basel, Switzerland)|April 23, 2022
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy EfficacySankaranarayan Kannan, Mary E Irwin, Shelley M Herbrich, et al.
Molecular Cancer Therapeutics|June 23, 2019
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic LeukemiaSankaranarayanan Kannan, Marisa J L Aitken, Shelley M Herbrich, et al.
American Journal of Clinical Pathology|March 25, 2017
CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution ExperienceSergej Konoplev, Xinyan Lu, Marina Konopleva, et al.
Gastroenterology|January 14, 2012
Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cellsMaria I Almeida, Milena S Nicoloso, Lizhi Zeng, et al.
Pageof 8